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THE ROLE OF TERATOGEN EXPOSURE ON NEURAL CREST CELLS 
IN THE PATHOGENESIS OF FETAL ALCOHOL SPECTRUM DISORDERS 
 
RICHARD BOHLING CAROZZA 
ABSTRACT 
Maternal consumption of ethanol during pregnancy contributes to a set of 
pathologies, grouped together as the fetal alcohol spectrum disorders, affecting as many 
as 5% of live births in the United States annually. Ethanol acts widely in the developing 
embryo, affecting many tissues, but causing deficits in neuronal and neural crest 
populations particularly. These deleterious effects cause archetypical craniofacial 
expression and neurological deficits, including microcephaly and neuronal dysfunction. 
Severity of symptoms is linked to frequency of maternal alcohol consumption as well as 
the maximum blood alcohol concentration reached by the mother. 
 The teratology of ethanol has been widely researched over the last four decades, 
with the link between the neural crest pathology and the fetal alcohol spectrum phenotype 
becoming clearer. Animal model studies have managed to replicate many of the 
symptoms seen in humans afflicted with fetal alcohol spectrum disorders, and have 
allowed us to elucidate the biochemical mechanisms behind the disease. There is no 
singular pathway responsible for the fetal alcohol spectrum disorders: over half a dozen 
models of dysfunction have been identified, and ethanol’s ability to react with a series of 
targets means that more pathways are likely to be discovered. 
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 Current theories regarding the effects of ethanol on the neural crest have 
implicated apoptosis of the cephalic neural crest, mediated by G-protein coupled 
receptors, activation of a phospholipase C pathway, and subsequent release of 
intracellular calcium; perturbations of the actin cytoskeleton leading to migration 
dysfunction of neural crest cells in the developing neural tube; lack of functional trophic 
molecules, specifically Shh, likely due to dysfunction of the cholesterol biosynthetic 
pathway; lack of retinoic acid production; oxidative stress, production of reactive oxygen 
species, and iron dysregulation; and genetics, which seems to confer greater susceptibility 
and resistance to ethanol in certain individuals. Ultimately, a global model for ethanol’s 
actions on the developing fetus eludes researchers, as do any potential treatments, and 
more research is required to further elucidate ethanol’s teratogenic mechanism. 
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INTRODUCTION 
 
Clinical Presentation of FAS, FASD 
 
 Ethanol is the most prevalent human teratogen, and is the largest known 
contributor to developmental disability (Smith, 2014). The link between prenatal alcohol 
exposure and negative health outcomes has been known anecdotally for centuries, with 
the ancient Greeks and Romans prohibiting maternal alcohol consumption. Western 
medicine often attributed alcohol-associated complications to heredity, and it wasn’t until 
the early twentieth century that the link was definitively made, and not until the 1960s 
was the condition fetal alcohol syndrome (FAS) formally recognized (Jones, 1973). 
Fetal alcohol syndrome and fetal alcohol spectrum disorders (FASD) refer to a 
range of conditions associated with prenatal alcohol exposure (PAE), leading to 
craniofacial abnormalities, growth problems, central nervous system dysfunction, and 
behavioral problems including deficits in learning, memory, attention span, 
communication, vision, and hearing in the developing fetus (CDC, 2015; Smith, 2014). 
Ethanol is capable of crossing the placenta, leading to a fetal alcohol blood content 
roughly two-thirds that of the mother. Due to the fetal liver’s inability to detoxify ethanol, 
the fetus relies on the maternal hepatic metabolism to carry out this function. Ethanol will 
thus persist in the amniotic fluid for hours after the mother finishes consuming alcohol. 
Animal studies have shown harmful, irreversible defects as a result of blood alcohol 
levels as low as 0.02%, a level expected from an average adult drinking one unit of 
alcohol (Smith, 2014). 
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The medical community steadfastly notes that all FASD are preventable by 
simply abstaining from alcohol consumption, and it is the opinion of the World Health 
Organization and most Western governments that there is no safe time or amount for 
pregnant women to drink, especially given that there is an absolute 0% risk of developing 
FASD if the mother abstains from all alcohol consumption during pregnancy (CDC, 
2015). Despite educational efforts to dissuade pregnant women from drinking and inform 
them of the risks to their child, prenatal alcohol exposure remains common. 7.6% of 
pregnant women reported drinking alcohol in the last 30 days, and 1.4% of pregnant 
women reported binge drinking in the same time period (CDC, 2015). 
Estimates in the United States indicate 0.2 to 1.5 infants out of every 1,000 live 
births are born with fetal alcohol syndrome annually; rates of FAS amongst African-
American populations of low socioeconomic background have been recorded as high 2.3 
per 1,000 live births, and some American Indian reservations have seen incidence rates as 
high as 8.0 per 1,000 live births (CDC, 2015; Sampson, 1997; Abel, 1995). Fetal alcohol 
spectrum disorders (which encompass FAS and other, milder manifestations of teratogen 
exposure) affect 9.1 to 50 per 1,000 live births annually according to low estimates. 
High-risk populations, such as the Western Cape Province of South Africa, witness 
incidence rates as high as 68.0 to 89.2 per 1,000 live births (Sampson, 1997; May, 2007; 
Smith, 2014; CDC, 2015). Prenatal alcohol exposure leads to many more spontaneous 
abortions and stillbirths, especially when consumption occurs during the first trimester of 
pregnancy (CDC, 2015). The severity of FAS, FASD phenotype is integrally linked to the 
time at which ethanol exposure occurs. Research has shown that ethanol consumption 
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during the first two months of pregnancy – the first especially – leads to infants 
significantly more likely to be born below the 10th percentile for height, head 
circumference, both indicative findings of FAS, FASD (Day, 1989). This is consistent 
with findings implicating the neural crest in the pathogenesis of FAS, FASD: the process 
of neurulation occurs primarily late in the first month, early in the second month of 
pregnancy (Hall, 2009). 
Both documentation of affected individuals and a wide array of animal models 
have suggested that prenatal alcohol exposure broadly suppresses neurodevelopment, 
including processes such as “neuronal induction, proliferation, survival, migration, 
synaptogenesis, and white matter formation” (Smith, 2014). While the degree and 
severity of symptoms is dependent on various genetic and environmental factors, the 
effect of ethanol is universally disadvantageous (May, 2011). Identifying the pathogenic 
mechanism of fetal alcohol syndrome spectrum disorders can be difficult; ethanol lacks a 
specific receptor, but rather interacts with hydrophilic portions of various proteins 
(Howard, 2011). The ability of ethanol to interfere with a large number of proteins is 
indicative of its broad-reaching and difficult to predict consequences on 
neurodevelopment. As a result, the quantity and frequency of ethanol consumption, the 
fetal stage of development during which prenatal alcohol exposure occurred, and other 
genetic and environmental factors determine the phenotype of fetal alcohol spectrum 
disorders (Smith, 2014). 
The most archetypical FAS phenotype includes dual growth complications and 
neurodevelopmental deficits, coupled with a distinctive craniofacial appearance 
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(Sampson, 1997). The clearest neurodevelopmental deficits include decreased cranial 
size, especially the prosencephalon (which corresponds with a greater susceptibility of 
the cranial neural crest to ethanol than the trunk neural crest); given that there is a direct 
correlation between brain size and facial structure, the decreased volume of the 
prosencephalon is a likely contributor to craniofacial deformities, in addition to decreased 
migratory cranial neural crest cells (Sampson, 1997; Smith, 2014; Czarnobaj, 2014). 
Infants with FAS are generally below the tenth centile in terms of height and/or weight. 
While variability in the FAS phenotype is expected, there are three critical diagnostic 
criteria with regards to craniofacial abnormalities: a smooth philtrum, a thin vermilion, 
and small palpebral fissures. A myriad of other organs can also be affected, including the 
eyes and heart (Sampson, 1997; see Table 1, Figure 1). 
 
Table 1. Typical symptoms in an individual with FAS or FASD. The FASD phenotype is highly variable, 
and it is unlikely that an individual with FASD will exhibit all, or even most, of the following (CDC, 2015; 
Riley, 2005). 
 
Behavioral Deficits 
 
Abnormal facial features   Difficulty with attention 
Difficulty in school (particularly math) Hyperactive behavior 
Intellectual disability or low IQ  Learning disabilities 
Low body weight    Poor coordination 
Poor memory    Poor reasoning and judgment skills 
Problems with the heart, kidneys, bones Shorter than average height 
Sleep and sucking problems as a baby Small head size 
Speech and language delays  Vision or hearing problems 
 
Neurophysiological Deficits 
 
Abnormal cellular migration  Agenesis of the commissure 
Agenesis of the corpus callosum  Apoptosis of neuronal progenitors, neural crest cells 
Basal ganglia anomalies   Brainstem anomalies 
Decreased cerebral asymmetry  Decreased synaptogenesis 
Decreased white matter formation  Lack of neuronal induction 
Lack of neuronal proliferation  Microcephaly 
Neuroglial heterotopias   Ventricular anomalies 
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Figure 1. Characteristic craniofacial abnormalities of FAS, FASD (Sampson, 1997). 
 
 
The Neural Crest 
 
The neural crest refers to the folded structure of neural ectoderm, located at the 
articulation of the neural and epidermal ectoderm in the neurula-stage vertebrate embryo 
(Hall, 2009). Early in embryonic development, induction occurs in the ectoderm to 
produce three layers: the neural ectoderm (becoming the central nervous system), the 
non-neural ectoderm (becoming the epidermis), and the intermediate cells, the vast 
majority of which become the neural crest. Neurulation occurs due to signaling between 
the neuroectoderm, ectoderm, and paraxial mesoderm. During the process of neurulation, 
the border of the neural ectoderm folds upon itself, becoming the dorsal neural tube, and 
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the neural crest cells undergo an epithelial-to-mesenchymal shift, allowing them to 
migrate from the closing neural folds (Hall, 2009; Gammill, 2003). 
 
 
 
The neural crest is populated by neural crest cells (NCCs), a diverse array of cells 
that give rise to an inordinately large number of cell types. While some neural crest cells 
remain in the central nervous system where they originate, many of them migrate large 
distances away from the CNS, populating various tissues. These neural crest cells are 
migratory, multipotent cells, forming mature cells at the site of their emigration. The 
contribution of NCCs to a particular tissue or organ may be direct (providing cells and 
contributing to the mass of the organ), or indirect (providing an environment, often with 
an associated inductive signal, to a growing population of cells). Some researchers have 
Figure 2. The developing embryo 
before, during, and after the process of 
neurulation. Neurulation is induced by 
the neural ectoderm (purple), non-
neural ectoderm (blue), and paraxial 
mesoderm (yellow). The neural folds 
(green) elevate at the beginning of 
neurulation, leading to the neural plate 
closing in upon itself to form the 
neural tube. Delaminated neural crest 
cells (green) will migrate to their 
future destination (Gammill, 2003). 
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recommended that the neural crest be considered one of the germ layers (currently the 
ectoderm, mesoderm, endoderm, increasing their number to four), given the extraordinary 
number of tissue types originating from the neural crest (Hall, 2009; Gammill, 2003). 
 
Table 2. A comprehensive, but not necessarily exhaustive, list of neural crest cell-derived tissues and cell 
types, either partially or in their entirety (Hall, 2009). 
 
Cell Types 
Adrenergic neurons   Angioblasts 
Calcitonin-producing (C) cells  Cardiac mesenchyme 
Cholinergic neurons   Chondroblasts, chondrocytes 
Chromaffin cells    Fibroblasts (mesenchyme) 
Glial cells    Melanocytes 
Merkel cells    Mesenchymal cells 
Odontoblasts    Osteoblasts, osteocytes 
Parafollicular cells   Rohon-Beard cells 
Satellite cells    Schwann cells 
Sensory neurons    Smooth myoblasts 
Striated myoblasts 
 
Tissues, Organs 
Adipose tissue    Adrenal gland 
Blood vessels    Brain 
Cardiac septa, valves, aortic arches  Connective tissue* 
Cornea     Craniofacial skeleton 
Dorsal fin    Dentine 
Endothelia    Eye 
Heart     Parasympathetic nervous system 
Peripheral nervous system   Smooth muscles 
Spinal ganglia    Striated muscles 
Sympathetic nervous system  Thyroid and parathyroid glands 
Ultimobranchial body 
* of the thyroid, parathyroid, thymus, pituitary, and lacrimal glands 
Objectives 
 An extraordinary amount of research has been performed over the last four 
decades, investigating the role of neural crest cells as the source of major pathologies of 
fetal alcohol syndrome and fetal alcohol spectrum disorders, and what the biochemical 
pathways perturbed by ethanol exposure are. This paper will help elucidate what the 
  8 
prevailing models are, their implications, and future research that needs to be done. It will 
also discuss any potential treatment options, and the effect of low dose ethanol exposure 
both in animal models and human epidemiological studies, as the effect of moderate, 
social drinking on the fetus is a source of great debate. 
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RESULTS 
 
The Role of G-Protein Coupled Receptors, Intracellular Calcium Release 
 
The aforementioned facial features are neural crest derived, and animal models 
have generated evidence that apoptosis of premigratory and early migratory cranial 
neural crest cells occurs after ethanol exposure (Flentke, 2011; Ahlgren, 2002). Pre-
migratory neural crest cells are the more susceptible to ethanol, with neural crest cells 
requiring larger doses after delamination and once migration has begun (Cartwright, 
1998). Human studies and animal models show that there are different effects of ethanol 
exposure on neural crest cell populations depending on location. The cranial neural crest 
is most predominately affected, which makes sense given their role in populating the 
craniofacial complex and the abundant craniofacial abnormalities. Trunk neural crest 
cells have lesser changes, and no deficits are noted in melanocytes (Rovasio, 2002; 
Smith, 2014; Czarnobaj, 2014). Ultimately, while many factors control cephalic end-
related abnormalities, the reduced number of cephalic neural crest cells due to apoptosis 
leads to a substantial proportion of FASD symptoms. This is confirmed by utilizing anti-
apoptotic drugs, which rescue normal craniofacial features (Rovasio, 2002; Cartwright, 
1998). The cell death is suggested to be apoptosis due to apoptotic marker labeling, 
pyknosis, and the ability to reverse apoptotic tendencies via treatment with caspase 
inhibitors (Cartwright, 1995; Cartwright, 1998; Flentke, 2014a). Programmed cell death 
is a natural part of embryogenesis. Research has indicated that ethanol-mediated 
apoptosis may be via inducing cell populations with a predisposition for apoptosis, 
hijacking a preexisting route for cell death (Sulik, 1988; Kotch, 1992). 
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In the cranial neural crest, ethanol has been shown to cause quick release of 
intracellular calcium stores within premigratory neural crest progenitors. This pathway 
seems to be mediated by a G-protein coupled receptor (GPCR) and associated 
downstream signaling, leading to activation of phospholipase Cβ and phosphoinositide-
mediated release of calcium (Flenkte, 2011; Garic-Stankovic, 2005). The neural crest cell 
apoptosis is calcium-dependent; administration of calcium chelators before ethanol 
treatment is sufficient to prevent cell death. Inhibition of either Gαi/o, phospholipase Cβ 
(PLCβ), or inositol triphosphate (IP3) is also sufficient to prevent ethanol-induced 
apoptosis, supporting the theory that ethanol acts through this pathway. Activation of 
Gαi/o also causes release of Gβγ, which can itself directly activate the phosphoinositol-
phospholipase C pathway (Debelak-Kragtorp, 2003; Garic-Stankovic, 2005). Release of 
intracellular calcium stores has been positively linked to neural crest cell apoptosis, 
however the target or targets for the increased calcium levels is still a source of some 
debate. 
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Figure 3. A proposed model of ethanol’s actions through the phosphoinositol-phospholipase C pathway, as 
given by Garic-Stankovic (2005). Solid lines represent pathways of trophic support, while dotted lines 
indicate the actions of ethanol. It’s believed that Gαi/o elevates IP3 and Ca2+, triggering apoptosis by 
saturating endogenous Ca2+ signaling systems. 
 
 
Research has implicated CaMKII (Ca2+/calmodulin-dependent kinase II). Neural 
crest cells showed quick, pervasive CaMKII activity after ethanol exposure, with activity 
increasing 300% above controls and occurring within 60 seconds of ethanol treatment. 
Ethanol’s specificity for CaMKII was confirmed by utilizing antagonists for CaMKII, 
CaMKIV, and protein kinase C (PKC); only inhibitors for CaMKII prevented ethanol-
induced apoptosis following ethanol exposure. Dominant-negative expression of CaMKII 
in these neural crest cells yielded similar results (Garic, 2011). Dominant-positive 
expression of CaMKII, meanwhile, caused apoptosis reminiscent of that seen after 
ethanol exposure. These results were seen in both chick and zebrafish embryos; this 
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indicates phylogenic conservation, and a similar mechanism may be present in humans as 
well (Garic, 2011; Flenkte, 2011). 
A proposed model for the pro-apoptotic action of CaMKII is via the protein β-
catenin, which has been shown to be phosphorylated and destabilized by CaMKII 
(Flentke, 2011; Smith, 2014). β-catenin is a component of the actin cytoskeleton, 
interacting with E-cadherin and promoting cell adhesion; more importantly, it also acts as 
a mediator of transcription, interacting with transcription factors TCF and LEF, 
ultimately providing trophic support for cells (Flentke, 2011; MacDonald, 2009). 
Ethanol-mediated decrease in β-catenin causes decreased expression of Slug, FoxD3, and 
Wnt6, factors necessary for neural crest survival and progression. Loss of these pathways 
causes pervasive apoptosis of the cranial neural crest and associated craniofacial 
abnormalities. Blocking the release of intracellular calcium or exogenously expressing β-
catenin in ethanol-exposed cells rescues the neural crest cells from apoptosis, indicating 
the source of NCC losses. (Flentke, 2011). These results are consistent with genetic 
models for β-catenin deficiency, which show similar cranial neural crest death and 
phenotypic craniofacial abnormalities (Brault, 2001). Researchers discovered three highly 
conserved CaMKII target sites on β-catenin, indicating that CaMKII phosphorylates β-
catenin directly, causing its degradation and subsequent apoptosis. Inhibiting other 
effectors that destabilize β-catenin, such as calpain, glycogen synthase kinase-3β, and 
protein kinase C were insufficient to ameliorate neural crest cell death, indicating that 
CaMKII’s direct phosphorylation of β-catenin is sufficient to mediate cellular apoptosis 
(Flentke, 2014a). These results have been confirmed in both chick and zebrafish 
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embryos, indicating an evolutionarily-conserved mechanism (Flentke, 2014b). These 
results also help justify results indicating that the cranial neural crest is more susceptible, 
and that earlier neural crest cell populations are sensitive due to preexisting apoptotic 
pathways, which coincides with research indicating that drinking during the first two 
months of pregnancy – when normal, endogenous apoptosis of neural crest cells would 
occur – leads to poorer outcomes (Abel, 1995; Smith, 2014; Hall, 2009). Wnt signaling is 
part of endogenous cell death, and increased Ca2+/abnormal Wnt signaling due to ethanol 
acts synergistically with these pathways. Yet, the downstream mechanism by which Wnt 
mediates apoptosis remains a mystery (Smith, 2014). 
 
Migration Abnormalities 
Neural crest cells have been shown to experience difficulty migrating following 
exposure to ethanol. In situ hybridization studies on Xenopus explored neural crest cells 
expressing Twist and Slug, two genes linked to neural crest migration. In control 
embryos, these cells are found to migrate ventrally, but were dorsally located following 
prolonged ethanol exposure. These results indicate disruption in normal neural crest 
migration. These effects were dose-dependent, with higher ethanol concentrations leading 
to clusters of cells located increasingly more dorsally (Shi, 2014). Migratory anomalies 
have been noted amongst neural crest cells at all neuraxis levels (Rovasio, 1995; Rovasio, 
2002). Ethanol exposure also causes neural crest cells to migrate in lesser quantities from 
the prosencephalon, mesencephalon, and rhomboencephalon (Cartwright, 1995; Rovasio, 
2002). In vitro and in vivo experiments have documented that ethanol treatment leads to 
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translocation of the neural crest cells, which did migrate properly, towards the lumen of 
the neural tube; this abnormal migratory pattern differs from standard movement, which 
is towards the lateral sides of the neural tube (Rovasio, 1995). Experiments in Xenopus 
showed that ethanol treatment causes decreased numbers of trunk and especially cranial 
neural crest cells migrating (Czarnobaj, 2014). Despite the effects on migration, ethanol 
does not seem to have a significant effect on neural crest cell induction, an early 
embryonic process (Shi, 2014). 
 
Figure 4. Real-time diagram of migratory tracts of cephalic, trunk neural crest cells in culture. Figure is 
given in 6 hour increments (indicated by dots), as either controls or after treatment with 150 mM ethanol. 
Neural tube explants are located on the left side and migrate towards the right; cephalic cells are over 24 
hours, trunk cells over 48 hours. There is a visually apparent decrease in motility in ethanol treated cells 
compared to controls. Bars = 100 µm (Rovasio, 2002). 
 
 
Cells of the neural crest are interconnected by zonula adherens, which occurs 
when a cell-cell interface is joined via connections to the intracellular actin cytoskeleton. 
By the “fixed cortex” model of mesenchymal cell migration, cells have protruding apical 
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processes, extending into the lumen. The cell will eventually follow the processes, sliding 
past the zonula adherens, and the trailing end of the cell will become detached. 
Ultimately, blocking interaction of neural crest cells with the basal extracellular matrix 
causes a transformation of the apical neural crest cell into the leading end; this causes 
movement towards the lumen of the neural tube (Bilozur, 1989; Rovasio, 2002). These 
perturbations between the extracellular matrix and neural crest cells resembled those 
observed after ethanol administration. 
Research by Czarnobaj (2014) investigated the effects of low-dose ethanol on 
Xenopus cranial and trunk neural crest cells and the subsequent effects on cell motility 
and migration, with the conclusion that ethanol, even at low doses, perturbs both cranial 
and trunk neural crest cells, although cranial NCCs to a greater extent. They also noted a 
difference in how cranial and trunk neural crest cells respond to ethanol when on collagen 
and fibronectin stratums. Yet, it remains unclear whether or not ethanol disrupts the 
extracellular matrix environment, or whether the effects on migration are mediated 
entirely by the cells (Czarnobaj, 2014). Interesting, too, is that the migratory effects have 
been repeatedly shown not to be transient; irregular migratory patterns persisted for 24 
hours beyond ethanol removal (Czarnobaj, 2014; Rovasio, 2002). 
The actin cytoskeleton of neural crest cells “undergoes disruption, thickening, 
collapse, and fragmentation” (Oyedele, 2013) following ethanol exposure, correlating to 
the aforementioned migratory abnormalities. Actin filaments comprise a cross-linked 
structure, which lines the cytoplasmic face of the plasma membrane, as well as fibers that 
run through the cytosol and into lamellapodia. Ethanol (in epithelial cells) has been 
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shown to cause collapse of the actin cytoskeleton, with an inverse relationship between 
ethanol concentration and polymerized cytoskeletal actin. The prevailing theory is that 
ethanol disrupts polymerization into F-actin, necessary for focal adhesions and migration 
(Banan, 2000). Further research suggested that ethanol’s disruptive role on cytoskeletal 
actin is not only dose-dependent, but also embryonic stage dependent. Indeed, 
experiments in chick embryos showed that the teratogenic effect of ethanol on 
cytoskeletal actin was observed only in embryonic stage 9, not stages 8 or 10. As the 
researchers noted, “the fact that similar concentrations of ethanol affect different stages 
of embryos differently, or conversely that embryonic or fetal cells at the same stage of 
development respond differently to lower versus higher ethanol concentrations, underlies 
the complexity of ethanol’s teratogenic effects” (Oyedele, 2013).  
The effects of depolymerization and cytoskeletal remodeling include retraction of 
filopodia and decreased numbers of focal adhesions, with actin bundles expressing less 
arborization and greater thickness (Banan, 2000; Oyedele, 2013). Intracellular calcium is 
also a mediator of cytoskeletal reorganization, and the ethanol-induced increases in 
intracellular calcium described before may play a role in neural crest cell migratory 
difficulties following ethanol exposure (Smith, 2014). 
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Figure 5. Avian cranial neural crest cells, rhodamine-immunolabeled. (A), (C), and (E) are untreated 
controls; (B) is 0.4% v/v ethanol-treated cells, in culture 48 hours; (D) is 0.2% v/v ethanol-treated cells, in 
culture 96 hours; (F), 0.2% v/v ethanol-treated cells, in culture 6 days. Arrows in (A) indicate actin 
filaments, which are not present in (B); arrows in (B) indicate cells in late mitosis. (D) shows that after 96 
hours in ethanol-treated culture, focal adhesions are lost (indicated by arrows) and ethanol-treated cells 
begin to congregate. Arrows in (F) indicate areas of cytoskeletal disorganization and breakdown. Scale 
bars: (A), (B): 5 µm; (C), (D): 3 µm; (E), (F): 2 µm (Oyedele, 2013). 
 
 
Cell adhesion molecules (CAMs) have been implicated in the ability of neural 
crest (and other) cells to migrate, as they create spatial organizations necessary for proper 
motility. Cell adhesion molecules are found on the extracellular surface of the plasma 
membrane and, as the name suggests, play an integral role in tissue structure by 
interconnecting cells with each other and the extracellular matrix. Research has 
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implicated L1-CAM as a target for ethanol, and ethanol concentrations as low as 1 mM 
have created improper cellular adhesion (Ramanathan, 1996). Human L1-CAM is part of 
the immunoglobulin superfamily, and has roles in neurite outgrowth and formation of 
bundles; it’s heavily expressed in growing cones of axons, and aids in migration (Wong, 
1995). 
Experiments utilizing recombinant human cDNA showed that L1-transfected 
mouse fibroblasts showed increased cell-cell adhesion, an improvement ablated by 
ethanol treatment. (Ramanathan, 1996; Rovasio, 2002). These interactions were seen in 
ethanol, as well as n-propanol and n-butanol, but not n-alcohols of 5 or more carbons, 
indicating that ethanol (and shorter n-alcohols) interact with a small, hydrophobic portion 
of the L1-CAM protein (Ramanathan, 1996). Mental retardation, hydrocephalus, and 
absence of the corticospinal tract and corpus callosum are both defining characteristics of 
severe FAS and genetic mutations in human L1-CAM. The congruence of phenotype and 
dysfunction of L1-CAM suggests that a potential role for L1-CAM in the pathogenesis of 
FAS (Wong, 1995; Ramanthan, 1996; Rovasio, 2002). 
The role of retinol as a teratogen and as the mediator of ethanol-induced 
disruption of neural crest cell migration will be discussed later. 
 
Folic Acid and FASD 
Dysregulation of folic acid has been known – independent on any ethanol 
involvement – to be a strong mediator of neurocristopathies and severe birth defects 
(Etchevers, 2006). Research has linked folic acid metabolism to the teratogenesis of 
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ethanol, with ethanol-treated mouse embryos expressing abnormal microRNAs (miRNA) 
and downregulated Hoxa1 expression; these defects were ameliorated by co-incubation 
with folic acid (Wang, 2009). Similar studies indicate that folic acid supplementation 
reduces ethanol-associated microcephaly; this may be mediated by folic acid reversing 
the downregulation of proteins of various metabolic processes, including isocitrate 
dehydrogenase (of the tricarboxylic acid cycle), serine/threonine protein phosphatase 
(involved in signal transduction), and proteins of the proteasome (Xu, 2008). The means 
by which folic acid rescues a wild-type phenotype is unclear. Early stages of 
embryogenesis require maximal nucleic acid and protein synthesis. Folic acid is 
necessary for these processes as a cofactor, and thus may reverse ethanol’s effects by 
either directly upregulating protein expression, or may upregulate other proteins to better 
handle the ethanol-mediated oxidative stress (Xu, 2008). Ethanol also increases renal 
excretion of folic acid by blocking its reabsorption, and supplementation with additional 
folic acid may help undo these effects (Muldoon, 1994). 
In addition to affecting folic acid metabolism, ethanol has been shown to produce 
hyperhomocysteinemia in the Xenopus fetus during the migration stage of neural crest 
cells (Stickel, 2000; Shi, 2014). Elevated homocysteine levels disturbs neural crest cell 
migratory behavior, possibly through a homocysteine-sensitive, NMDA-like receptor 
expressed by early migratory neural crest cells; hyperhomocysteinemia leads to defects of 
the neural tube and craniofacial abnormalities (Brauer, 2002). Supplementation of 
ethanol-exposed Xenopus fetus with 5-methyltetrahydrofolate, the most biologically 
active form of folic acid, reduces homocysteine levels and rescues migratory behavior of 
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the neural crest cells (Shi, 2014). Folic acid seems to rescue neural crest cell migratory 
abilities via its direct actions on various proteins and nucleic acids, and by reducing 
homocysteine levels, which are by themselves teratogenic; the relative contribution of 
each of these pathways to the dysfunction of neural crest migration remains unclear. 
However, the abundance of research does indicate that mothers who have consumed 
ethanol during pregnancy would be well-advised to supplement with folic acid, if they are 
not doing so already (Shi, 2014). 
 
Trophic Support 
Defects to the prosencephalon are severe enough to categorize FAS along the 
holoprosencephaly (HPE) spectrum in many cases (Sulik, 1984). Holoprosencephaly is a 
failure of the fetal prosencephalon to bifurcate into the two cerebral hemispheres. 
Premature alcohol exposure, neural crest cells, and expression of Shh seem to be 
correlated, specifically on the midline specification of cerebral, craniofacial, and oral 
structures (Aoto, 2008). Animal models have shown that Shh expression in the gastrula 
organizer node progresses to the axial mesendoderm, which gives rise to the notochordal 
plate (Echelard, 1993). Specifically, prechordal plate (PrCP) cells, which comprise the 
anterior-streak derived axial mesendoderm, migrate to below the anterior neural plate, 
and are pivotal for proper development of the brain and facial structures (Aoto, 2009).  
Various mutations have been implicated in the pathogenesis of HPE, perhaps 
most significantly Sonic Hedgehog (SHH) (Higashiyama, 2007). Prenatal alcohol 
exposure decreases Shh expression in these structures (Echelard, 1993). Despite this 
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evidence, the molecular pathway and role of Shh remains unclear, as while decreased 
levels of Shh were reported in chick (Ahlgren, 2002), mouse (Higashiyama, 2007), and 
zebrafish (Li, 2007) embryos after treatment with ethanol, Xenopus reported higher levels 
of Shh (Yelin, 2007). However, current theories suggest that if ethanol is consumed 
during a specific developmental window for the prechordal plate, it will result in the HPE 
phenotype (Higashiyama, 2007). The current model suggests that Shh is necessary for 
PrCP cell survival; a lack of PrCP cells, which are critical for the process of neurulation, 
would disrupt the neurodevelopment and produce the HPE phenotype. Thus, early 
prenatal alcohol exposure may lead to craniofacial abnormalities indirectly, via disruption 
of the neuroectoderm rather than the neural crest (Aoto, 2008; Aoto, 2009; Hall, 2009; 
Smith, 2014). 
However, Shh has been consistently shown to prevent apoptosis in neural crest 
cells and other populations (Smith, 2014). Shh is most prevalently expressed in the 
cranial neural crest, and embryos treated with ethanol or anti-Shh antibodies exhibit 
similar phenotypes: decreased head size, craniofacial abnormalities, and apoptosis of 
cranial neural crest. Exogenous Shh also rescued ethanol-treated neural crest cells from 
death (Ahlgren, 2002; Aoto, 2008). The facial skeletogenic neural crest (FSNC) is the 
rostral portion of the neural crest that gives rise to skeletal structures of the face, such as 
the maxilla and mandible. Removal of the FSNC or the preceding cranial neural crest 
leads to a phenotype strongly resembling HPE (Brito, 2006). Inhibition of Shh expression 
leads to destruction of the FSNC, as well as associated neural crest cells; researchers have 
concluded Shh is vital for FSNC cell survival during migration to the branchial arch 
  22 
(BA1). This Shh appears to be derived from the anterior ventral foregut endoderm (Brito, 
2006). 
However, researchers noted that lack of Shh signaling was not sufficient enough 
to produce the ethanol phenotype: in severe ethanol-induced HPE, there is near-complete 
ablation of the telencephalon and eyes, which is not observed in Shh-/- embryos. This is 
consistent with results showing that, in mice models, ethanol-induced decreases in Shh 
expression were exhibited only in the anterior prechordal mesendoderm, triggering 
apoptosis (Aoto, 2008). 
Post-translational modification of fetal proteins is critical for the sequential order 
of embryogenic steps, and sterol and fatty acid-modified Shh confers upon it different 
functionality, which is vital for its proper formation, translocation, and function, 
depending on its fetal location and timing (Li, 2007). Research has indicated that these 
post-translational modifications may be the target of ethanol as a teratogen in the Shh 
pathway. This is exemplified by research showing that individuals with Smith-Lemli-
Opitz syndrome (SLOS), an autosomal recessive condition resulting in 7-
dehydrocholesterol reductase deficiency and dysfunctional cholesterol synthesis, show a 
characteristic phenotype similar to that of FAS-associated HPE (Kelley, 1996). Similar 
results are seen by exposing embryos to agents that block cholesterol synthesis or 
selectively decrease its levels (Cooper, 2003). The prevailing theory is that ethanol acts 
by disrupting HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) reductase activity, 
causing decreased free cholesterol in fetal cells and circulation, as well as by inhibiting 
hepatic ACAT (acetyl-coenzyme A acetyltransferase); both HMG-CoA reductase and 
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ACAT are instrumental in proper cholesterol biosynthesis, and their inhibition could 
result in defective Shh leading to the HPE phenotype seen in FAS (Polo, 2003). Other 
research has definitively shown that ethanol, even in low doses, inhibits covalent 
modification of Shh by cholesterol, disrupting Hedgehog (Hh) signal transduction and 
causing a constellation of symptoms mirroring FASD; supplementation with cholesterol 
rescues embryos from this fate (Li, 2007). 
 
Figure 6. In mammals, the metabolic, transport pathways controlling cholesterol metabolism. Free 
cholesterol is either synthesized de novo from acetyl-CoA, or can be obtained by hydrolyzing cholesterol 
esters present in the cell (often via LDL molecules). Ethanol is believed to disrupt both HMG-CoA 
reductase and ACAT (both marked by a red star), and the subsequent cholesterol dysfunction contributes to 
the pathologies of FAS, FASD. 
 
Contradicting the role of post-sterol modification as the dysregulation of Shh are 
results indicating that, while ethanol does disrupt Shh signaling leading to neural crest 
cell apoptosis at some embryonic stages, it is not a universal occurrence. Shh-deficient 
chick neural crest cells at the onset of migration will exhibit apoptotic tendencies, a 
  24 
behavior ameliorated by exogenous Shh administration. However, similar studies on 
mouse embryos at the same stage found that ethanol did not perturb Shh levels, and yet 
neural crest cell death and craniofacial defects still occurred (Yamada, 2005). Another 
study found that rat cranial neural crest cells, the population responsible for craniofacial 
abnormalities, actually express increased Shh following ethanol exposure (Wentzel, 
2009). One would expect the proposed model (HMG-CoA reductase and ACAT 
interference) to apply more broadly, throwing its validity into question. Additional 
research needs to be performed to gauge the role of Shh and post-sterol signaling in the 
FASD phenotype. 
Further confounding these results, however, are other studies indicating that 
ethanol-mediated decreases in Shh are via protein kinase A (PKA) activation. PKA is an 
endogenous inhibitor of Shh signaling in the neural tube. In anterior PME cells of mice, 
ethanol has been shown to activate adenylyl cyclase activity, thereby upregulating the 
levels of cyclic AMP (cAMP), which in turn activates PKA. Ethanol also causes 
translocation of PKA to the nucleus, where it phosphorylates transcription factor CREB, 
which causes a subsequent drop in Shh levels; these results are reversed with treatment of 
a PKA inhibitor, indicating that PKA is indeed the pathway by which ethanol causes Shh-
induced HPE (Aoto, 2008). However, the same researchers investigated the role of 
oxidative stress in the development of ethanol-induced HPE. Vitamins C and E (L-
ascorbic acid and DL-α-tocopherol, respectively) are dietary antioxidants, and 
supplementation of mice with these compounds in conjunction with ethanol exposure 
reduced the incidence of HPE from 25% to 5.2% (Aoto, 2008). How (or if) the three 
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proposed models – post-translational sterol modification, PKA signaling, and oxidative 
stress – act together to produce HPE is unclear. 
As discussed previously, the cranial neural crest cells seem to be particularly 
susceptible to the teratogenic effects of ethanol, with the trunk neural crest affected to a 
lesser degree and other neural crest cell populations not at all. Investigations into the 
genetic expression in the cranial versus trunk neural crest cell provide some insight into 
the fundamental differences between these cell populations. In the cranial neural crest of 
rats, ethanol administration increases expression of Shh, Bmp-4, and T box-2; these 
effects are not seen in trunk neural crest (Wentzel, 2009). Bmp-4 is of particular interest, 
as it promotes embryonic apoptosis (Graham, 1996) and modulates L1-CAM expression 
(Wilkemeyer, 1999), both of which have been independently identified as contributing to 
the FASD pathology. Wentzel (2009) also found that cranial neural crest cell Hox genes 
(Hoxa1, Hoxa4, Hoxa5, but not Hoxa2) were downregulated (almost no expression), 
while the trunk neural crest cells had upregulated expression of all 4 Hox genes (Wentzel, 
2009). These effects begin to elucidate the particular sensitivity of the cranial neural crest 
to teratogen exposure, but not other regions. 
Various other trophic factors have been shown to function in neural crest 
proliferation, migration, and survival. Experiments using chick embryos investigated the 
developmental window between the beginning of migration through the closure of the 
neural tube, during which the cranial neural crest is especially susceptible to ethanol 
exposure. Researchers discovered that ethanol-mediated apoptosis of the neural crest 
during this developmental window was reversed by treatment with neurotrophin-3 (NT3), 
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which aligns well with the model proposed by Garic-Stankovic (2005) regarding the role 
of GPCRs and intracellular calcium (Jaurena, 2011). NT3 binds to its receptor, 
tropomyosin receptor kinase C (TrkC), which is a receptor tyrosine kinase. Similar 
restorative results were seen in mouse embryos by co-incubating with ethanol and HB-
EGF, which binds to ErbB1, ErbB4 – both part of the epidermal growth factor (EGF) 
receptor family – which are also both receptor tyrosine kinases (Kilburn, 2006). GM1 
ganglioside also has protective effects, and will be discussed later (Chen, 1996b). 
 
The Role of Retinol, Retinoic Acid 
 Retinoic acid is synthesized from retinol (vitamin A), and regulates many steps of 
embryonic development (Yelin, 2004). Within the central nervous system, retinoic acid is 
considered vital for “stimulation of axon outgrowth in particular neuronal sub-types, the 
migration of the neural crest, and the specification of the rostrocaudal position in the 
developing CNS (forebrain, midbrain, hindbrain, spinal cord).” Lack of vitamin A or 
retinoic acid leads to catastrophic birth defects (Maden, 1992; Madden, 1996). Retinoic 
acid has been shown to be vital in gastrulation, as well as in establishing neural axes 
during CNS development, primarily through modulation of the Hox genes. Retinoic acid 
administration has been shown to induce Hox expression, which is vital in determining 
the axes of the neural crest and other embryonic structures (Maden, 1996; Hall, 2009). In 
experiments utilizing quail embryos, neural crest cells were produced normally in the 
absence of retinol, but following migration, apoptotic tendencies were exhibited. Retinoic 
acid is thus believed to preserve and maintain crest-derived neuronal precursor cells. 
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Failure of this preservation leads to malformations in the dorsal root ganglia and the 
neural tube, which becomes unable to extend neurites into the periphery (Maden, 1996). 
Mammalian models have shown ethanol to be a competitive inhibitor for retinol 
dehydrogenase, which normally converts retinol to retinoic acid. If ethanol and retinol are 
both substrates for the retinol dehydrogenase enzyme, then prenatal alcohol exposure 
could lead to temporary decreases in retinoic acid while the enzyme preferentially 
detoxifies ethanol to acetic acid (Duester, 1991). 
 These effects are coupled to the fact that ethanol treatment increases levels of 
retinol by inhibiting retinol dehydrogenase’s ability to detoxify it (Duester, 1991). 
Somewhat paradoxically, retinol itself acts as a teratogen. Embryonic treatment of retinol 
leads to craniofacial abnormalities, including a cleft palate; this is believed to be due to 
faulty neural crest cell migration. These suspicions are supported by animal model 
studies utilizing quail embryos: neural crest cells exposed to hypervitaminosis A gravely 
affects their locomotory abilities. As a whole, retinol-exposed cells exhibit significantly 
less mobility, with lamellipodia unable to remain extended. This effect is coupled to, and 
in part due to, a culmination of factors, including reduced cellular outgrowth, 
dysfunctional or sometimes absent lamellipodia, lack of cellular adhesion to the 
extracellular matrix, and dysmorphologies in shape, deviating from a normal triangular 
shape to fusiform. (Thorogood, 1982). 
 In amphibians, the Spemann’s organizer is a gastrula-stage structure that is 
capable of producing a secondary body axis if transplanted; it induces dorsalization of 
ventral mesoderm and specifies the neuroectoderm. In Xenopus, the Spemann’s organizer 
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utilizes retinoic acid signaling during the gastrula stages, and as a result this structure 
may be susceptible to ethanol exposure during this embryonic period. Thus, some of the 
embryonic abnormalities attributed to prenatal alcohol exposure may be the result of 
dysfunctional retinoic acid signaling (Yelin, 2005). Disorder of Spemann’s organizer 
contributes to malformation of the rostro-caudal and dorsal-ventral axes, and increased 
size of the prechordal plate and notochord coupled with decreased spinal cord size (Yelin, 
2005; Yelin, 2007). 
 
Oxidative Stress  
 Ethanol has been repeatedly shown to have adverse effects on glucose metabolism 
in the body. Ethanol consumption has been shown to reduce levels of necessary proteins, 
such as the transport protein Glut1, perturb the mitochondria and reduce the enzymes of 
the electron transport chain, and reduce available ATP stores, thereby leading to 
oxidative stress (Cunningham, 2003). 
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Figure 7. Aerobic, anaerobic cellular respiration in humans. Glycolysis is a metabolic process conducted in 
the cytosol, in which glucose is catabolized into two molecules of pyruvate, generating two molecules of 
ATP; the pyruvate then, in the presence of oxygen, enters the mitochondria and is catabolized further by the 
tricarboxylic acid cycle to produce NADH, which is fed into the electron transport chain to generate the 
majority of ATP (Cunningham, 2003). 
 
Oxidative stress can generate reaction oxygen species (ROS), which are cytotoxic. 
Many cells counteract reactive oxygen species through the actions of the enzyme 
superoxide dismutase, which converts superoxide (O2
-) into hydrogen peroxide (H2O2), a 
less dangerous species (which is further degraded by other enzymes). Research has 
shown that ethanol treatment on the neural crest generates significant levels of reactive 
oxygen species (Davis, 1990; Chen, 1996a; Kotch, 1995). Immunoassays for superoxide 
dismutase in neural crest cells indicate a lack of this enzyme, which may explain the 
neural crest’s susceptibility to a host of teratogens, including ethanol (Davis, 1990). 
Reactive oxygen species production led to craniofacial abnormalities and neural crest cell 
death reminiscent of ethanol treatment. The teratogenic effects of ethanol on the neural 
crest were ameliorated by supplementation with exogenous superoxide dismutase and 
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other free radical scavengers, such as α-tocopherol and catalase (Davis, 1990; Kotch, 
1995; Chen, 1996a). A phenotype similar to that of ethanol administration on neural crest 
cells was achieved after treatment with xanthine/xanthine oxidase, a system that produces 
free radicals. These effects were ameliorated by superoxide dismutase and catalase (free 
radical scavengers). Rescuing the neural crest cells from death suggests that “free radicals 
play a significant role in ethanol-induced NCC death” (Chen, 1996a). 
This generation of free radicals after ethanol administration produces loss of 
microvilli, leakage of radiolabeled chromium (Cr), and other pathologies associated with 
the cell membrane (Davis, 1990). The notion that the cell membrane is a major target of 
ethanol-mediated toxicity is supported by increased fluidity of the membrane following 
ethanol exposure. This effect is reversed by exogenous gangliosides, glycolipids whose 
function is to stabilize plasma membranes (Chen, 1996b). There may also be some cross-
talk between the production of free radicals and apoptotic tendencies: N-acetylcysteine 
(NAC) is an antioxidant agent, and has been shown to decrease ethanol-derived apoptosis 
in the neural crest (Wentzel, 2009). 
Why exactly the neural crest either generates more reactive oxygen species or is 
particularly susceptible to their pathogenic actions is unclear (Smith, 2014). Some 
researchers have investigated the role of free iron in this pathway. Generally, free iron 
does not exist in the body; it’s bound to functional proteins such as hemoglobin, transport 
proteins such as transferrin, or storage proteins such as ferritin. However, ethanol is 
oxidized by alcohol dehydrogenase into acetaldehyde, producing NADH; NADH 
liberates stored iron from ferritin, increasing free iron levels in the cell. Ethanol also 
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prevents conversion of reactive ferrous iron (Fe2+) into non-reactive ferric iron (Fe3+). 
Additionally, the production of acetaldehyde and its subsequent catabolism often 
generates free radicals, which exacerbates this process (Shaw, 1998; Chen, 2000; Shaw, 
1999). Cellular free iron can produce free radicals via the Fenton reaction, seen in Figure 
5. Lipid peroxidation was found after release of free iron from ferritin; this process was 
confirmed to be iron-dependent, as the effects were reversed by adding the iron chelator 
deferoxamine (Double, 1998). These results are consistent with research on ethanol’s 
effects on production of reactive oxygen species and their subsequent effects on the cell 
membrane. 
 
Fe2+ + H2O2  Fe3+ + -OH + .OH 
Figure 8. Free iron (Fe2+) can generate free radicals via the Fenton reaction. 
 
These results are especially relevant given that chronic ethanol consumption 
increases iron absorption from the intestines and iron stores in the liver; fetal iron also 
increases following ethanol exposure (Chen, 2000). While these results suggest a 
potential link, they have not definitively connected the generation of free radicals to 
dysfunctional iron metabolism, and more research is required to clarify the relationship. 
 
Genetics 
 FAS and FASD are highly variable diseases, in their symptoms, degree of 
severity, and in how alcohol causes their presentation. Anecdotal evidence indicates that 
some women who binge drink throughout pregnancy have children who present with few 
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if any symptoms along the FASD spectrum, while some women who ingest relatively low 
amounts of alcohol present with severe FAS or stillbirth. There is strong evidence that the 
etiology of FAS and FASD is complicated, with evidence that the drinking patterns and 
peak concentration, maternal age, hormonal levels, and nutrition, and genetics are all 
significant co-factors (Smith, 2014; Debelak, 2000). 
Studies on twins of alcoholic mothers showed that, despite identical alcohol 
exposure in utero, monozygotic twins showed significantly more concordance with 
regards to FASD phenotype than dizyogotic twins (Streissguth, 1993). Additionally, in 
chicks (Debelak, 2000) and zebrafish (Loucks, 2004), the extent of craniofacial 
abnormalities following ethanol exposure is highly variable, and in zebrafish has been 
linked to specific genetic variables. Most of these are involved in the metabolism of 
alcohol – alcohol dehydrogenase, the first (and rate-limiting) step in detoxifying ethanol, 
is perhaps the most widely implicated – but investigators are likely to find many more in 
subsequent studies. This indicates a strong genetic component that is likely to persist in 
humans, and explains why some individuals with FASD also have craniofacial defects 
(Smith, 2014; Debelak, 2000). 
Platelet-derived growth factor (Pdgf) is one of many signaling molecules that 
modulates neural crest cell migration, survival, and ultimately the development of the 
craniofacial mesenchyme. It is a receptor tyrosine kinase, activating PI3K and mTOR to 
mediate its downstream effects. Research showed that the pdgfra heterozygotes and 
mutants show neural crest cell migratory abnormalities resulting in cleft palate, and in the 
presence of ethanol, even more severe craniofacial anomalies. The researchers propose 
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that wild-type pdgf serves a protective function for neural crest cells that is deficient in 
those with the pdgfra allele. Heterozygotes and pdgfra mutants are even more susceptible 
to the teratogenic effects of ethanol than wild-type individuals (McCarthy, 2013). Studies 
on a South African population have shown that presence of the alcohol dehydrogenase 
B*2 allele, which has greater enzymatic activity and thus lessens ethanol’s half-life, 
results in a lesser incidence of FAS and FASD, further supporting the notion that the 
pathogenesis following prenatal ethanol exposure is both environmental and genetic 
(Viljoen, 2001). 
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DISCUSSION 
The discovery of the exact mechanisms involving ethanol’s effect as a teratogen 
are of paramount importance; as many as 1.5 and 50 live births per 1,000 are affected by 
fetal alcohol syndrome and fetal alcohol spectrum disorders, respectively. The total 
annual cost on both the family and society due to FASD was $14,342 per child annually, 
translating to as much as $230 billion in the United States (Sampson, 1997; CDC, 2015; 
Popova, 2012). The effect of ethanol on neural crest cells has been explored vigorously, 
with more than a half dozen models describing its effects. Neural crest cells are 
implicated most directly with the craniofacial abnormalities seen in individuals with FAS, 
and some with FASD, and likely contribute to a host of other pathologies of FASD, 
including visual and auditory, cardiac, and neurological deficits (Hall, 2009). 
Substantive research has shown that the cranial neural crest is more susceptible to 
ethanol exposure (Rovasio, 2002), inducing apoptosis (Cartwright, 1995; Cartwright, 
1998). Current models suggest that ethanol activates a GPCR, leading to activation of 
phospholipase Cβ and subsequent increase in intracellular calcium levels (Flentke, 2011; 
Garic-Stankovic, 2005). Research has implicated CaMKII as the source of calcium-
mediated apoptosis, possibly by its phosphorylation of β-catenin and subsequent 
modulation of transcription of trophic factors (see figure 9). However, Flentke (2011) 
notes that GSK3β is an inhibitor of β-catenin activity as well, and while it has been 
implicated in FASD, it is considered calcium-independent. How GSK3β, as well as other 
potential β-catenin modulators such as PKC and calpain, affect β-catenin activity and 
contribute to the FASD phenotype is unclear. It remains unknown, as well, what (if any) 
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activity Gαi/o has, and which GPCR is affected by ethanol, perhaps the most salient 
mystery of all. While a near-complete picture has been painted with regards to the GPCR 
pathway of ethanol neural crest cell toxicity, more research is necessary to fill in the 
canvass. 
 
 
Figure 9. Proposed model by which ethanol induces neural crest cell apoptosis via a GPCR. Ethanol 
stimulation causes a rapid (within seconds) increase in intracellular calcium levels, believed to be caused 
by a phospholipase C-mediated pathway. CaMKII is known to cause effects on β-catenin, a transcription 
factor regulator, but other mediators may have a role as well. Both the GPCR, and all the relevant parties 
regulating apoptotic behavior, are unknown (Flentke, 2011). 
 
Migratory difficulties of neural crest cells are well known, occurring at all 
neuraxis levels (Rovasio, 1995; Rovasio, 2002). The prevailing theory is that 
disturbances in the migration of neural crest cells is due to dysfunction of the actin 
cytoskeleton; F-actin polymerization is decreased in the presence of ethanol (Banan, 
2000; Oyedele, 2013). However, the mechanism by which ethanol perturbs F-actin 
polymerization is unclear, and is a necessary avenue of research. It is also unknown why 
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the perturbation of F-actin polymerization by ethanol occurs during some stages of 
embryonic development, but not others (Oyedele, 2013). Some have suggested a link 
between intracellular calcium – known to be increased in the presence of ethanol and 
known to be a modulator of the actin skeleton – and improper migration, but the 
connection has yet to be proven (Smith, 2014). 
Folic acid deficiencies have been shown, independent of ethanol, to cause 
dysfunction of the neural tube and neural crest, leading to conditions such as spina bifida. 
Interestingly, supplementation with folic acid in conjunction with prenatal ethanol 
exposure seems to lessen its teratogenic effects (Wang, 2009). Assuredly an interesting 
development, it raises more questions than it answers, however. Folic acid is a necessary 
cofactor for nucleic acid and protein synthesis, both of which are especially necessary 
during early embryonic proliferation. Yet, the target for folic acid remains unclear: folic 
acid may upregulate proteins necessary to counteract ethanol’s toxicity, or it may act on 
transcription factors (Xu, 2008). Folic acid also increases homocysteine levels in 
Xenopus fetuses; hyperhomocysteinemia has been independently shown to disturb 
migratory patterns in neural crest cells (Stickel, 2000; Shi, 2004; Brauer, 2002). 
Homocysteine acts on a homocysteine-sensitive, NMDA-like receptor; the exact nature 
of this receptor, its mechanism of action, and why it’s only expressed during early 
embryonic stages is a topic for additional research. Some have noted, too, that renal 
excretion of folic acid increases following alcohol consumption, and ethanol-exposed 
embryos may simply be folic acid-deficient (Muldon, 1994). This, however, has not been 
explored substantively in the embryo, and is a likely candidate for further research. 
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Shh has been implicated in FASD, with ethanol exposure decreasing Shh levels in 
many animal models, and Shh-deficient animals sharing a phenotype similar to that of 
ethanol-induced holoprosencephaly (Echelard, 1993; Ahlgren, 2002; Higashiyama, 2007; 
Li, 2007). Higashiyama (2007) suggested that the effects of ethanol on Shh during a 
specific developmental window induce HPE, but they fail to provide a possible 
mechanism by which this would occur. Yelin (2007), however, found that Xenopus 
embryos treated with ethanol actually have higher concentrations of Shh, confounding 
previous results. These results were repeated by Yamada (2005) and Wentzel (2009) in 
mice and rats, respectively, and found no change or an increased level of Shh. Future 
studies should repeat these experiments to confirm the phylogenic conservation of 
ethanol-induced Shh decrease. Additionally, Shh-deficient mutants (Shh-/-) do not express 
holoprosencephaly as catastrophic as severe ethanol-exposed embryos (Aoto, 2008). Yet, 
exogenous Shh does rescue neural crest cells after ethanol exposures from apoptosis, 
indicating that Shh does play a role, yet it is likely only one of many modulators 
(Ahlgren, 2002; Aoto, 2008). 
How ethanol affects Shh is itself a source of debate. Ethanol has been shown in 
non-embryonic cells to inhibit both HMG-CoA and ACAT, enzymes involved in 
cholesterol metabolism (Polo, 2003). The theory is that Shh, which requires post-
translational sterol modification, dysfunctions with altered cholesterol levels (Li, 2007). 
However, other researchers have found that PKA activity is increased following ethanol 
exposure, and causes a reciprocal drop in Shh (Aoto, 2008). While possible for both 
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mechanisms to play a significant role in disrupting Shh signaling, more investigation is 
required to confirm the authenticity of the two pathways. 
Retinoic acid is the product of retinol, and is critical for modulating embryonic 
development, especially via the Hox genes (Yelin, 2004; Maden, 1996; Hall, 2009). 
Ethanol and retinol are both believed to be substrates for retinol dehydrogenase, which 
normally converts retinol into retinoic acid. Thus, ethanol may disturb the proper 
alignment of the axes of the neural tube and other structures. However, retinol has itself 
been shown to be teratogenic, disrupting normal neural crest migration. While it is clear 
that ethanol modulates an effect on the neural crest via inhibiting retinol dehydrogenase, 
it remains unclear whether the effect is due to increased levels of retinol or decreased 
levels of retinoic acid. 
Oxidative stress has been repeatedly implicated in the pathogenesis of FASD. 
Davis (1990) showed that the neural crest is especially susceptible to the effects of 
reactive oxygen species following ethanol exposure due to lack of superoxide dismutase. 
Research shows that these reactive oxygen species perturb the cell membrane (Davis, 
1990; Chen, 1996b) and prevent apoptosis (Wentzel, 2009). The exact mechanism of 
action by these free radicals is contentious. Free radicals are known to disrupt the cell 
membrane independently, but some have investigated the role of iron, whose conversion 
to ferric from ferrous iron is inhibited by ethanol (Shaw, 1998; Chen, 2000). Free iron in 
the cell generates additional free radicals (feeding the cycle), and causes lipid 
peroxidation, explaining some of the membrane damage associated with ethanol exposure 
(Shaw, 1999; Double, 1998). While there is evidence that iron generates free radicals, 
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contributes to lipid peroxidation seen in ethanol exposure, and has dysfunctional 
metabolism following alcohol consumption, the link between the three is presumptive, 
and Smith (2014) notes that additional research is necessary. 
The link between genetics and prognosis following prenatal alcohol exposure is 
conclusive: studies comparing monozygotic and dizygotic twins have shown strong 
hereditary ties (Streissguth, 1993), confirmed in animal models of FASD (Debelak, 2000; 
Loucks, 2004). Researchers have investigated obvious genes in the metabolism of ethanol 
(e.g., alcohol dehydrogenase), and found a link between the more active form of the 
enzyme and a greater immunity to the teratogenic effects of ethanol (Debelak, 2000). 
Finding proper genetic ties between those who are more or less susceptible to prenatal 
alcohol exposure will require a much more profound understanding of the mechanisms 
that mediate the disease, as only then will a comprehensive list of target genes be known. 
Other targets, such as pdgf, may be discovered as researchers explore various genes 
associated with things such as cell proliferation, migration, and survival (Viljoen, 2001). 
The role of environmental factors – such as hormonal levels, diet, and maternal age – has 
not been adequately explored, and will assuredly be an area of fervent research in the 
coming years. 
 
Low Dose Ethanol 
More work is required to understand the role of small doses of ethanol on the 
developing fetus. The CDC, U.S. Surgeon General, and the American Academy of 
Pediatrics are all steadfast in stating that there is no safe amount or type of alcohol, or 
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time or consumption, which is safe for the fetus (CDC, 2015). They note that in addition 
to ethanol’s role in FAS and FASD, prenatal alcohol exposure is conclusively linked to 
premature deliveries, stillbirth, miscarriage, and sudden infant death syndrome (SIDS). 
Animal studies also indicate grave effects of even mild ethanol concentrations, those 
exhibited by an average adult after one unit of alcohol. 
 Studies that have found no link between moderate maternal alcohol consumption 
and disadvantageous fetal outcomes (or have concluded that prenatal alcohol 
consumption at low doses can actually be beneficial) are fraught with problematic 
assumptions. For instance, a study by Niclasen (2013) found that children whose mothers 
consumed ethanol in doses up to 90 units throughout the pregnancy (roughly 2 drinks per 
week) exhibited better mental health at age 7. However, women in this category were 
significantly more likely to be educated, abstain from smoking and soda consumption, 
exercise, and have low BMIs; all of these factors are likely to lead to better child 
outcomes. While the study noted this, it failed to account for these variables in its 
statistical analysis and provided no evidence that, all other factors the same, moderate 
alcohol consumption provides any benefit. It also fails to take into account present views 
that ethanol affects more complex cerebral processes, and the brain at age 7 is incapable 
of performing this tasks in any capacity. Indeed, many symptoms of FASD don’t present 
until pubescence. 
 The overwhelming body of evidence concludes that any form of prenatal ethanol 
exposure is universally disadvantageous. When controlling for factors like smoking and 
socioeconomic background, Alati (2013) found a link between maternal consumption of 
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the equivalent of two glasses of wine or two pints of beer with decreased cognitive and 
developmental outcomes by age 11. Research by Andersen (2012) found a correlation 
between first trimester alcohol intake and an increased risk of spontaneous abortion and 
stillbirth. While the increased risk in poor fetal outcomes was dose-dependent, they noted 
8%, 42%, and 107% increases in fetal death following 0.5-1.5, 2-3.5, and ≥4 drinks per 
week, respectively. 
 These results are in addition to animal model studies directly showing the effect 
of small to moderate amounts of ethanol. While many studies utilize ethanol 
concentrations as high as 200 mM to ensure deleterious effects for their studies, some 
researchers were specifically interested in the effects of low dose ethanol. Previously, 
research by Czarnobaj (2014) was discussed, concluding that cranial and trunk neural 
crest cells exhibit decreased cellular motility and migration following ethanol at low 
concentrations, leading to persistent (up to 24 hours) effects on cytoskeletal remodeling 
and motility. These experiments were performed at ethanol concentrations at 0.5 mg/ml 
(10.9 mM), which is designed to emulate the blood alcohol content of a 100 lb woman 
after 1 unit of alcohol. These results strongly suggest a teratogenic effect of ethanol at 
even social drinking levels (Czarnobaj, 2014). Similar results were acquired after 
injection of ethanol, creating a 7 mM solution; these embryos showed defects in the 
neural crest and neural tube (Rovasio, 2002). While at slightly higher concentrations (26 
mM, or roughly two drinks for a 100 lb woman), social levels of drinking showed 
decreased β-catenin expression, which as explored earlier, mediates gene expression that 
helps prevent apoptosis in neural crest cells (Flentke, 2011). Even more frightening 
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results were found by Ramanathan (1996), that ethanol concentrations as low as 1 mM 
caused statistically significant reductions of cell-cell adhesion due to human L1-CAM. 
Inhibition reached half of maximum at concentrations of 7 mM, still within the range of 1 
unit of alcohol for a 100 lb woman. 
 These results suggest that small amounts of ethanol can have a potently 
teratogenic effect on the developing fetus. It also indicates that this sensitivity isn’t 
isolated to one particular pathway: evidence exists for migratory dysfunction, β-catenin 
dysregulation, and decreased cellular adhesion. All signs point towards even modest 
amounts of ethanol exposure causing potent effects on the fetus, however significantly 
more research is necessary to accurately categorize its effects. While more research is 
assuredly needed to confirm and fully categorize the effects of small doses of ethanol, 
present evidence overwhelmingly suggests it has a potent effect. The vast majority of 
research has utilized levels of ethanol seen only in binge drinking; now that the effects of 
ethanol have been better discovered, elucidating whether similar effects are mediated by 
lower doses of ethanol is necessary. 
 
Conclusion 
Curing a disease such as FAS or FASD is extremely difficult: missing critical 
periods during embryonic development is nearly universally irreversible, and prevention 
is a much easier means of eliminating FASD. While we are discovering that some 
compounds – L-ascorbic acid, 5-methyltetrahydrofolate, neurotrophin-3 for example – 
have been shown in animal models to ameliorate some of the pathologies of the neural 
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crest, and some genetic strains have been shown to confer a modest resistance to the 
effects of ethanol, we still lack a broad enough understanding to truly discuss treatment 
options. Indeed, a curative treatment for FAS, FASD may never exist.  
Various models for ethanol’s teratogenic effects are being constructed, but they 
are likely not mutually exclusive; to tackle all the pathologies associated with prenatal 
ethanol exposure may require half a dozen different treatments. For pregnant women who 
have consumed alcohol, soon there may be nascent treatment options for the following 
day, but the medical community should be wary promoting these. It would be incredibly 
unwise to cast prenatal ethanol exposure as something that requires fixing, rather than 
something that should simply be avoided at all costs. 
Because of the omnipresence of alcohol consumption in everyday life in many 
cultures, a complete eradication of FAS and FASD is unlikely. Even with widespread 
education, given that a majority of pregnancies in the United States are unplanned, social 
alcohol consumption may still lead to an array of children born with FAS or FASD due to 
their mothers consuming alcohol while unaware of their own pregnancies (CDC, 2015). 
Nevertheless, the persistence of FAS and FASD is disheartening, considering that it is an 
entirely preventable illness.  The failure of Western society and many physicians to 
accept the overwhelming evidence that both binge and social drinking contributes to the 
FASD phenotype is shocking and saddening, to say the least, and may be remembered in 
later years as a movement not altogether different from other science deniers such as 
those of the anti-vaccine movement. The fundamental question when tackling the debate 
over moderate drinking alcohol while pregnant should be: is the small benefit yielded 
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from a single alcoholic drink worth the potential risk of irreversible, potentially 
debilitating, birth defects posed by consuming a teratogen?  
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